First-of-its-kind Alzheimer's blood test made by Malvern company gets FDA clearance

A Malvern company has received FDA clearance for a first-of-its-kind blood test to help diagnose Alzheimer's condition Wellbeing experts say the test could revolutionize the assessment and care of people with Alzheimer's the preponderance common form of dementia